Did you know?
Submitting an article
Benefits of publishing with NPG


Did you know?

  • That over 50,000 recipients will receive via e-mail a copy of the table of contents for the Oncogene issue in which your article is published.
  • That there are an average of 500,000 page views across the Oncogene web site per month.
  • That Oncogene has an impact factor of 6.318
  • That on average authors receive a first decision on their paper within 32 working days.

Submitting an article

To read about how to prepare your article, please click on Instructions for Authors. If you are ready to submit an article please click on Online Submission.


Benefits of publishing with NPG

Nature Publishing Group is a dynamic, innovative, creative company, committed to publishing high quality, independently peer-reviewed research and review material. NPG uses pioneering technologies, innovative formats and world class production to provide premium information for scientific researchers in the public and private sectors, government agencies and educators.

A key strength of NPG is its close relationship with the scientific community. Working closely with scientists, listening to what they say, and always placing emphasis on quality rather than quantity, has made NPG the leading scientific publisher at finding innovative solutions to scientists' information needs. Publishing with the NPG family provides an author with a wide range of benefits.

Tradition of excellence — offering scientists the finest outlets in print and online.

Nature Publishing Group does not require authors of original research papers to assign copyright of their published contributions. Authors grant NPG an exclusive licence to publish, in return for which they can re-use their papers in their future printed work. NPG's author licence page provides details of the policy and a sample form. Authors are encouraged to submit their version of the accepted, peer-reviewed manuscript to their funding body's archive, for public release six months after publication. In addition, authors are encouraged to archive their version of the manuscript in their institution's repositories (as well as on their personal web sites), also six months after the original publication. Authors should cite the publication reference and doi number on any deposited version, and provide a link from it to the published article on the NPG website. This policy complements the policies of the US National Institutes of Health, the Wellcome Trust and other research funding bodies around the world. NPG recognizes the efforts of funding bodies to increase access of the research they fund, and strongly encourages authors to participate in such efforts.

Online presence - reducing publication times

Oncogene has adopted NPG's online submission system, which allows authors to submit papers via the Web. Speeding up the submission and refereeing process, this system also allows you to view the status of your paper online.

Weekly publication online

New articles in Oncogene, as in all NPG journals, are published weekly online ahead of the archival print issue, ensuring the research is made publicly available and can be cited as soon as possible after acceptance for publication. The online publication is identical to the printed version and is not a preliminary, unedited version, thus maintaining the journal's tradition of excellence and the integrity of the published record.

Supplementary online material

Authors are invited to submit additional supporting material such as data sets or video for publication in the online version of the journal. Online supplementary material makes the most of the Web as a delivery platform and can often give articles greater depth, making them more useful to readers.


Authors who choose to publish in any NPG journal can be assured that its staff's publishing, editorial and production skills are committed to maintaining the highest possible quality and standards.

Exposure - widest possible readership

All NPG journals including Oncogene, are available online via site licenses to academic, corporate and government institutions and consortia. Journals are available to members of these institutions at the click of a mouse, adding speed and visibility to authors' research papers.

Regular free e-mail alerts

Content published in Oncogene has the potential to reach scientists around the world who have signed up for NPG's free table of contents e-alerts, ensuring additional exposure to authors. These e-alerts allow recipients to click through to the full article if they subscribe or work at an institution with a site license, or click through to the article's abstract for other readers.

Focused subject areas on

From immunology to physics, genetics to materials, subject-specific areas provide a focused environment for readers, providing a monthly updated focus for a particular field.

Abstracting and indexing

Oncogene is included in the leading abstracting and indexing services including ISI, MEDLINE, EMBASE and BIOSIS. Extensive reference linking to MEDLINE, ISI, Chemport and others via services such as Crossref and DOI numbers provide seamless online linking between articles and databases.

Media coverage

The Nature press office provides information about exceptionally interesting papers published throughout NPG. More than 2,000 journalists and media organizations worldwide subscribe to the press service, ensuring that papers receive maximum exposure in the world's most important media channels including newspapers, magazines, radio and television.

Extending science further - global collaborations

NPG and Oncogene support some projects aimed at making current research available to a broader community of scientists and practitioners.

All NPG journals, including Oncogene, are in WHO's HINARI (Health InterNetwork Access to Research Initiative) program, which provides free access to public institutions in developing countries.

Extra navigation